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Abstract
Experimental metastases in the brain of mice are infiltrated by microglia, and parabiosis experiments of green
fluorescent protein (GFP+) and GFP− mice revealed that these microglia are derived from circulating monocytes
(GFP+, F4/80+, and CD68+). These findings raised the question as to whether microglia (specialized macrophages)
possess tumoricidal activity. C8-B4 murine microglia cells were incubated in vitro in medium (control) or in medium
containingboth lipopolysaccharide and interferon-γ. Controlmicrogliawere not tumoricidal against a number ofmurine
and human tumor cells, whereas lipopolysaccharide/interferon-γ–activated microglia lysed murine and human tumor
cells by release of nitric oxide. Parallel experiments with murine peritoneal macrophages produced identical results.
Neither activated microglia nor activated macrophages lysed nontumorigenic murine or human cells. Collectively,
these data demonstrate that brain metastasis–associated microglia are derived from circulating mononuclear cells
and exhibit selective and specific tumoricidal activity.
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Introduction
Throughout the body, the connective tissue not only plays a tissue-
supportive role but also embeds host-defense cells that are capable of
phagocytosing foreign materials, microorganisms, and dead cells. In
the absence of connective tissue in the brain, the surveillance functions
must be performed by cells that are similar to macrophages in other
organs [1]. In humans, under normal conditions, microglia are small
cells evenly distributed within the white and gray matter that make
up approximately 5% of the glial populations in the white matter of
the corpus callosum [1,2]. In mice, more microglia are localized in
the gray matter than in the white, particularly in the hippocampus,
olfactory telencephalon, basal ganglia, and substantia nigra. The propor-
tion of the residentmicroglia populations in the adultmouse brain varies
from 5% in the cortex and corpus callosum to 12% in the substantia
nigra [2]. These so-called “resting” microglia were once thought to be
largely inactive; however, recent work describes their active patrol of
the healthy brain, using their motile processes to constantly survey the
microenvironment [3,4]. It is under pathologic conditions, such as
injury or inflammation, that immediate and drastic changes take place
among microglia, that is, their nucleus and cytoplasm enlarge, they ac-
quire the ability to divide, and they rapidly become mobile and phago-
cytose materials [2–4].
Microglia are generally considered to be brain macrophages that are
derived from monocytes and colonized by way of circulating monocyte
invasion into the brain on pathologic developments such as apoptosis of
neurons [1,5]. Microglia and macrophages share molecular markers
such as MAC1, F4/80, and FcIgG1/2b [6,7]. It is largely recognized
that some microglia develop from a pool of blood monocytes and
can colonize the brain early in development [8–10]. Lipopolysaccharide
(LPS) and interferon-γ (IFN-γ)–activated microglia isolated from the
adult brain are more similar to macrophages infiltrating the central ner-
vous system (CNS) than naive microglia of the brain [11]. Moreover,
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LPS has been shown to extend the life span of cultured mouse microglia
by increasing the expression of Bcl-xl and suppressing the induction of
apoptosis and autophagy [12].
The role of macrophages and microglia in tumorigenesis is widely
disputed. A large body of evidence suggests that in some situations,
macrophages can promote tumor growth, metastasis, and angiogenesis
[13,14], whereas in others, macrophages are tumoricidal by selectively
recognizing and destroying tumor cells [15–18]. Data suggest that these
behavioral changes are largely dependent on the context of the specific
tumor type and its microenvironment [19–22]. Although the presence
of macrophages and microglia has been reported in both clinical and
experimental specimens of brain metastasis, their exact function is un-
clear [23–30]. To determine whether, similar to macrophages [13–15],
microglia can be activated to the tumoricidal state, we incubated normal
(control) and activated C8-B4 murine microglia [6] or murine macro-
phages with several nontumorigenic and tumorigenic murine and
human cells. We report that activated microglia behave similarly to
macrophages by inducing cytotoxicity in a variety of tumor cells, but
not in nontumorigenic cells, through the release of nitric oxide (NO).
Materials and Methods
Cell Line and Culture Conditions
The spontaneously immortalized murine C8-B4 microglial cell line
[6] was the gift of Dr D. Trisler (The University of Maryland, College
Park, MD). The PC14P human lung adenocarcinoma cell line [31] was
obtained fromDr N. Saijo (National Cancer Center Research Institute,
Tokyo, Japan). The B16-BL6 cell line is a highly metastatic and invasive
variant [32,33] derived from B16 mouse melanoma [34]. The K-1735
C4 melanoma syngeneic to C3H-/HeN mice [35] was a gift from Dr
M. L. Kripke (MD Anderson Cancer Center, Houston, TX). The
MDA-MB-231 is an ER-negative human breast carcinoma cell line
[36] and was a gift from Dr R. Cailleau (Department of Medicine,
MD Anderson Cancer Center). The immortalized murine brain endo-
thelial cell line was a gift from Dr R. R. Langley (MD Anderson Cancer
Center) [37]. It was isolated from a transgenic mouse whose tissues har-
bor a temperature-sensitive SV40 large Tantigen (H-2K b-tsA58mouse)
[5,26]. The immortalized murine astrocyte cell line was established by
our laboratory also from the H-2K b-tsA58 mouse [26]. The immortal-
ized murine astrocyte and brain endothelial cell lines were maintained
in high-glucose Dulbecco minimal essential medium supplemented
with 10% fetal bovine serum (FBS), 2 mM L-glutamine, sodium pyru-
vate, nonessential amino acids, and vitamin solution (Life Technologies,
Inc, Rockville,MD), at the permissive temperature of 33°C in 8%CO2.
The 3LL-LM cell line is the Lewis lung carcinoma syngeneic to the
C57BL/6 mice [11]. Unless otherwise stated, all tumor cell lines were
maintained as adherent monolayer cultures in Eagle minimum essen-
tial medium supplemented with 10% FBS (Thermo Fisher Scientific
HyClone, Logan, UT), L-glutamine, pyruvate, nonessential amino acids,
two-fold vitamins, and penicillin-streptomycin (GIBCO/Invitrogen,
Carlsbad, CA) and incubated at 37°C in 6.4% CO2 with balance of
air. The C8-B4 line was maintained in Dulbecco minimal essential
medium supplemented with 10% FBS, 2 mM L-glutamine, sodium
pyruvate, nonessential amino acids, and vitamin solution (Life Technol-
ogies, Inc). All reagents used for tissue culture were free of endotoxin as
determined by the Limulus amebocyte lysate assay (Associates of Cape
Cod, Woods Hole, MA), and all cell lines were free ofMycoplasma spp,
Sendai virus, mouse hepatitis virus, pneumonia virus of mice, minute
virus of mice, mouse parvovirus (MPV1, MPV2, andMPV3), Theiler’s
murine encephalomyelitis virus, murine norovirus, reovirus type 3,
mouse rotavirus, ectromelia virus, lymphocyte choriomeningitis virus,
polyoma virus, lactate dehydrogenase–elevating virus, mouse adenovirus
(MAD1 and MAD2), mouse cytomegalovirus, K virus, mouse thymic
virus, and Hantaan virus (assayed by the Research Animal Diagnostic
Laboratory, University of Missouri, Columbia, MO). Cells used in this
study were from frozen stock, and all experiments were performed within
10 in vitro passages after thawing.
Animals
Female transgenic green fluorescent mice (C57BL/6-Tg [ACTB-
EGFP]10sb/J) were purchased from Jackson Laboratory (Bar Harbor,
ME). The mice were housed and maintained under specific pathogen-
free conditions. Age-matched female C57BL/6 mice were purchased
from the Animal Production Area of the National Cancer Institute,
Frederick Cancer Research Facility (Frederick, MD). Animal facilities
were approved by the American Association for Accreditation of Labo-
ratory Animal Care and met all current regulations and standards of
the US Department of Agriculture, US Department of Health and
Human Services, and the National Institutes of Health. The mice were
used in accordance with institutional guidelines when they were 8 to
10 weeks old.
Parabiosis
To identify cells infiltrating metastases in the brain parenchyma and
investigate their origin, we used a parabiosis model system. A transgenic
female green fluorescent mouse and a female C57BL/6 (wild-type)
mouse were anesthetized with pentobarbital (0.5 mg/g body weight;
Abbott Laboratories, Chicago, IL). Opposing sides of the bodies were
shaved. The skin was cleaned with iodine and alcohol and was widely
excised from the shoulder (humerus) joint to the hip (femur) joint. The
muscle layer was separated by dissection. The two mice were then anas-
tomosed as follows: the muscle layer of each mouse was approximated
by interrupted absorbable sutures (4-0 vicryl; Ethicon, Inc, Somerville,
NJ) and then was sutured skin to skin by continuous nonabsorbable
suture (4-0 prolene; Ethicon, Inc). Additional continuous anchoring
suture to secure the anastomosis was placed over the anastomosis site.
The parabionts were wrapped with elastic band to relieve wound ten-
sion. Establishment of common circulation was confirmed as previously
described 2 weeks after the procedure [38].
To minimize postoperative pain, analgesia was used for all mice as
per the University of Texas MD Anderson Cancer Center Institutional
Animal Care and Use Committee StandardOperating Procedures based
on the US Department of Agriculture Animal Welfare Act Regulations
and PHS Policy. The nonsteroidal anti-inflammatory agent carprofen
(Rimadyl; Pfizer Animal Health, New York, NY) was given to all our
animals postoperatively as 5 mg/7.5-ml gelatin cubes for 2 to 3 days.
Injection of Mouse Lung Cancer Cells (3LL) into the
Internal Carotid Artery
To produce metastatic tumors in the brain, 3LL cells were harvested
from subconfluent cultures by a 2-minute exposure to 0.25% trypsin
and 0.02% EDTA. Then, medium containing 10% FBS was added,
and the cells were washed once in serum-free medium and resuspended
with the adjustment of the number of cells to 2.5 × 104 in 100 μl of
Ca2+- and Mg2+-free Hank’s balanced salt solution (HBSS). Cell viabil-
ity was determined by trypan blue exclusion, and only single-cell sus-
pensions of greater than 95% viability were used for injection. Both
mice of parabionts were anesthetized by intraperitoneal injection of
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pentobarbital sodium (0.5g/kg of body weight; Nembutal; Abbott Lab-
oratories), restrained on a corkboard on the back, and placed under a
dissecting microscope. The head of the wild-type mouse was stabilized
(on the corkboard) with a rubber band placed between the teeth of the
upper jaw. The hair over the trachea was shaved, the neck was prepared
for surgery with alcohol-iodine, and the skin was cut by a mediolateral
incision. After blunt dissection, the trachea was exposed. The muscles
were separated to expose the right common carotid artery, which was
then separated from the vagal nerve. The artery was prepared for an
injection distal to the point of division into the internal and external
carotid arteries. A ligature of 5-0 silk suture was placed in the distal part
of the common carotid artery. A second ligature was placed and tied
proximal to the injection site. The artery was nicked with a pair of
microscissors, and a less-than-30-gauge glass cannula was inserted into
the lumen. To ensure proper delivery, the cells were injected slowly, and
the cannula was removed. The second ligature was tightened, and the
skin was closed by sutures. To inject cells into the internal or external
carotid artery, the glass cannula was threaded into the internal or exter-
nal carotid artery, respectively. All intracarotid artery injections were
always done under a dissecting microscope, and all required a glass can-
nula with a diameter smaller than 30 gauge.We prepared such cannulas
from 1-mm-diameter glass capillary tubes that were heated and then
stretched. The diameter could be varied by varying the amount
of stretching, and each cannula could be used repeatedly. The cannula
was fixed to a 1-ml plastic syringe by melting the hub around the can-
nula [39].
Necropsy and Tissue Processing
Three weeks after the intracarotid injection, the wild-type (tumor-
bearing) mice were separated from the transgenic green fluorescentmice
(C57BL/6-Tg [ACTB-EGFP] 10sb/J) that were killed. The wild-type
mice were allowed to survive, but when they became moribund, they
were killed by injecting an excessive dose of Nembutal (1 g/kg of body
weight). The skull was opened, and the brain was harvested and embed-
ded in an optimal cutting temperature compound (Miles, Elkhart, IN)
for frozen sectioning.
Immunohistochemistry
C8-B4 microglia were plated at a density of 2 × 105 cells/chamber in
four-chambered slides. The following day, cells were fixed in 4% para-
formaldehyde and washed with PBS. The samples were blocked briefly
in 5% normal horse serum + 1% normal goat serum in PBS and then
incubated at 4°C with an antibody directed against either CD68, Iba-1,
or F4/80 (1:200 each) overnight. The slides were subsequently washed
three times with PBS and then incubated with appropriate peroxidase-
conjugated secondary antibody for 1 hour at room temperature. The
slides were then rinsed with PBS and incubated with diaminobenzidine
(Research Genetics, Huntsville, AL). The cells were visualized using an
Olympus microscope (BX-51) with a DPTI digital camera (Olympus,
Center Valley, PA).
Colocalization of F4/80 and CD68
Frozen tissues in the optimal cutting temperature compound were
sectioned (6-8 μm), mounted on positively charged slides, and air-dried
for 30 minutes. The sections were fixed in cold acetone for 10 minutes
and then washed three times with PBS for 3 minutes each. Double
staining for F4/80 and CD68 required a protein block with 5% normal
horse serum and 1% normal goat serum for 5 minutes. Rabbit anti-
human CD68 polyclonal antibody (sc-9139; Santa Cruz Biotechnol-
ogy, Inc, Santa Cruz, CA) was applied at a 1:100 dilution in blocking
solution. After overnight incubation at 4°C, the slides were washed
three times with PBS for 3 minutes each time. Sections were blocked
for 5 minutes at room temperature, and goat antirabbit A594 antibody
(A11037; InvitrogenCorp) was added at a 1:600 dilution and incubated
in blocking solution for 1 hour at room temperature. The slides were
then washed three times for 3 minutes each time with PBS. Sections
were blocked again for 5 minutes and incubated at 4°C with rat anti-
mouse F4/80 monoclonal antibody (1:100 dilution; Serotec, Raleigh,
NC) in blocking solution overnight at 4°C. Tissue sections were then
washed three times with PBS for 3 minutes. Protein blocking was
performed for 5 minutes, and goat antirat Cy-3 antibody (GxRt-Cy3;
Jackson Immunoresearch, West Grove, PA) was added at a 1:600 dilu-
tion and incubated for 1 hour in blocking solution at room tempera-
ture. The slides were washed three times for 3 minutes each time with
PBS, and nuclei were stained at room temperature for 10 minutes
withHoechst 33342 (Molecular Probes, Carlsbad, CA). The slides were
then washed three times with PBS for 3 minutes each time. Cover slips
were placed on top of the slides using glycerol in PBS with fluorescent
mounting medium (propyl gallate; Acros Organics, Morris Plains, NJ).
Images were captured with an Olympus microscope (BX-51) with an
attached DP71 digital camera and processed with DP Controller and
DPManager software (Olympus, Center Valley, PA). Color codes detect-
ing cells were green for cells from transgenic green fluorescent mice
(C57BL/6-Tg [ACTB-EGFP]10sb/J), red for cells expressing CD68,
blue for expressing F4/80, and gray for nuclei [38].
Peritoneal Exudate Macrophage Isolation
Peritoneal exudate macrophages (PEMs) were collected by perito-
neal lavage, in 10 ml of 37°C calcium-free and magnesium-free HBSS,
from C57BL/6 mice given intraperitoneal injections of 1.5 to 2.0 ml of
sterile thioglycollate broth (Baltimore Biological Laboratories, Cockeys-
ville, MD) 4 to 5 days before harvest. The lavage returns were centri-
fuged at 200g for 10 minutes at room temperature, and the cells
were resuspended in serum-free medium, seeded at 100,000 cells/well
into 96-well tissue culture plates (Falcon 3072 Microtest III; Becton
Dickinson, Lincoln Park, NJ), and allowed to attach to plastic at 37°C
for 45 minutes. Nonadherent cells were removed by rinsing the wells
with HBSS, and the cells were refed with fresh complete minimal
essential medium. The monolayers routinely contained greater than
98% pure peritoneal macrophages as assessed by morphologic and
phagocytic criteria [40].
Tritiated Thymidine Assay
Log-phase target tumor cells were plated at a density of 3 × 105 and
incubated overnight to allow attachment. The following day, 1 × 105
C8-B4 microglia or C57BL/6 peritoneal macrophages were plated
per well in a 96-well plate and tumor cells were labeled with 3 μCi
of 3H-thymidine for 18 hours. On day 3, macrophages were activated
with a combination of IFN-γ (10 ng/ml) and LPS (100 ng/ml) for at
least 2 hours. Microglia were either left untreated or were treated with
one of the following: vascular endothelial growth factor (50 ng/ml),
interleukin-6 (IL-6; 50 ng/ml), IL-8 (50 ng/ml), or a combination of
IFN-γ (10 ng/ml) and LPS (100 ng/ml) for at least 2 hours. For the
inducible NO synthase (iNOS) inhibitor, NG-monomethyl-L-arginine
(NMA; Sigma, St Louis, MO), microglia were pretreated for 2 hours
with 3 mM NMA before IFN-γ and LPS activation. After treatment,
2 × 104 3H-labeled tumor cells were added to both of the untreated
microglia and/or macrophages as well as the cytokine-treated microglia
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and/or macrophages. As a control, 3H-labeled tumor cells were also
cultured alone. All cultures were done in triplicate. Microglia and/or
macrophages and tumor cells were incubated for an additional 72 hours
when the cells were lysed with 100 μl of 0.1 M KOH, and radioactivity
was measured using a scintillation counter. Percentage cytotoxicity was
calculated as a ratio to 3H-labeled tumor cells cultured alone.
Assay for Nitrite Production
Nitrite accumulation in the culture supernatant was measured in
a colorimetric assay as described previously [41]. At different times,
50-μl aliquots of supernatants were mixed with equal volumes of Griess
reagent (1% sulfanilamide and 0.1% napthylenediamine dihydro-
chloride in 2.5% phosphoric acid). The mixtures were incubated for
10 minutes with shaking, and A565 was measured with the use of a
microplate reader. The concentration of nitrite was determined by com-
paring it with a standard solution of sodium nitrite in medium [41].
Statistical Analysis
Levels of significance for comparison between samples were deter-
mined by Student’s t test distribution. P ≤ .05 was considered to be
statistically significant.
Results
In the first set of experiments, we examined metastases in the brain of
nude mice injected in the carotid artery with murine 3LL cells 4 weeks
before the histology-immunohistochemistry evaluations. As can be seen
in Figure 1, the metastases were infiltrated by a large number of cells
expressing microglia markers F4/80, CD68, and ionizing calcium-
binding adapter molecule-1 (Iba-1).
Because microglia and PEM exhibit nearly identical markers, we
wished to determine whether microglia originate from circulating
monocytes that also give rise to PEM. To do so, we examined the pres-
ence of microglia in a brain metastasis model established in a C57BL/6
(wild-type) mouse parabiosed to a transgenic green fluorescent mouse
(C57BL/6-GFP+). This parabiosis model allows for the visualization
of infiltrating cells to the brain (Figure 2). Reconstituting mice with a
single injection of GFP+ bonemarrow cells will largely home to the liver
and lungs; therefore, we used the parabiosis model, which allows for
continuous release of bonemarrow cells into the circulation [42].Mouse
3LL lung tumor cells formedmetastases in the brains of wild-type mice,
and these lesions were infiltrated by cells originating from both the
C57BL/ 6-GFP+ mouse and the wild-type mouse. Infiltrating cells were
identified as follows: 1) cells from wild-type expressing either CD68 or
Iba-1 (red), 2) cells from wild-type expressing F4/80 (blue), 3) cells from
wild-type expressing CD68/Iba-1 and F4/80 (pink), 4) cells from
C57BL/6-GFP+ expressing neither F4/80 nor CD68/Iba-1 (green), 5)
cells fromC57BL/6-GFP+ expressingCD68/Iba-1 (yellow), 6) cells from
C57BL/6-GFP+ expressing F4/80 (sky blue), and 7) cells fromC57BL/6-
GFP+ expressing CD68/Iba-1 and F4/80 (white). Data shown in Fig-
ure 2 suggest that circulating monocytes expressing CD68/Iba-1 and/
or F4/80 infiltrate into the brain metastases. Importantly, a number of
non-GFP+ cells were also found to express CD68/Iba-1 and F4/80 either
alone or in combination, suggesting that the population of residentmicro-
glia are also either recruited or expanded in response to the metastatic
brain lesion.
Next, we confirmed the identity of the immortalized C8-B4 murine
microglia cells by examining these cells for classicmicroglial/macrophage
markers, including Iba-1, F4/80, and CD68. Immunohistochemical
analysis of these cells revealed strong expression of these antigens in
both microglia and macrophages. In addition, to assess the functional
ability of the microglial cells to phagocytose, they were cultured with
polystyrene-coated beads and analyzed for their ability to ingest the
blue-labeled beads. The phagocytic activity of C8-B4microglia has been
shown previously [6], and we confirmed this characteristic behavior as
well (data not shown).
Both macrophages and microglia can be potently activated by IFN-γ
and LPS to express a variety of integral cell surface proteins necessary
for immune function [16,43]. Importantly, LPS + IFN-γ–activated
microglia isolated from the adult brain are similar to CNS-infiltrating
macrophages [11], and recent data suggest that LPS confers a survival
advantage to cultured mouse microglia by simultaneously increasing
the expression of Bcl-xl and suppressing the induction of apoptosis
and autophagy of themicroglia [12].We compared the tumoricidal activ-
ity of microglia pretreated with numerous cytokines against melanoma
cells. Treatment of microglia with a combination of LPS and IFN-γ in-
duced a significant increase in cytotoxicity against both B16-BL6 and
K-1735 melanoma tumor cells (data not shown). In contrast, pretreat-
ment of microglia with vascular endothelial growth factor, IL-6, or IL-8
had no significant effect on microglial-mediated cytotoxicity against
melanoma cells (data not shown). In addition, to rule out cytotoxicity
induced by nutrient deprivation, we performed the same experiment
using various cell types of normal origin, instead of microglia. LPS +
IFN-γ–treated fibroblasts, astrocytes, and brain endothelial cells failed
to induce cytotoxicity in the B16-BL6 tumor cells (data not shown).
The induction of cytotoxicity was, therefore, unique to LPS + IFN-γ–
activated microglia.
The ability of activated macrophages to induce cytotoxicity of tumor
cells has been recognized formore than 30 years [16].Using the B16-BL6
Figure 1.Microglia infiltrating into experimental brainmetastases. 3LL lung cancer cells were injected in the carotid artery of nudemice. Four
weeks later, the mice were killed, and the brain tissue was harvested, processed, and stained with hematoxylin and eosin to verify tumor
location. Specific antibodies were then applied to frozen, fixed brain tissue sections, and immunohistochemical analysis of the resulting
tumors revealed F4/80+, CD68+, and Iba-1+ cells infiltrating the experimental metastases.
Translational Oncology Vol. 3, No. 6, 2010 Microglia-mediated Selective Cytotoxicity Brantley et al. 383
and K-1735 melanoma tumor cells, we compared the tumoricidal ac-
tivity of LPS + IFN-γ−treated macrophages with activated microglia.
Both LPS + IFN-γ–treated macrophages and –activated microglia
induced similar levels of cytotoxicity (∼80%) against the B16-BL6 cells
(Figure 3). The K-1735 melanoma cells also exhibited comparable
levels of cell death, although that induced by the activated microglia
was slightly higher (∼75%) than the LPS + IFN-γ–treated macro-
phages (∼50%; Figure 3). Importantly, in two different melanoma cell
lines, tumoricidal activity of microglia is potent and equivalent to that
of macrophages.
To determine the specificity of microglia-induced cytotoxicity, we
examined the effects of these cells on cells from a normal, nontumor ori-
gin. Activatedmicroglia did not affect the viability of murine 3T3 fibro-
blasts and human fibroblasts (Table 1). Notably, activated microglia
also had no cytotoxic effects on cells from the brain microenvironment,
including immortalized brain endothelial cells and astrocytes (Table 1).
To further examine this apparent specificity in microglia-mediated
tumor cell cytotoxicity, we cocultured tritiated thymidine-labeled B16-
BL6 cells with 3T3 fibroblasts and examined the ability of the microglia
cells to induce cytotoxicity in the labeled melanoma cells. As a control,
we performed a similar experiment using both tritiated thymidine-
labeled 3T3 fibroblasts cultured alone or in combination with B16-
BL6 cells. Microglia acted in a tumor cell–specific fashion, selectively
killing only the B16 melanoma cells (data not shown). Activated micro-
glia had no cytotoxic effects on 3T3 fibroblasts, cultured either alone
or in combination with melanoma tumor cells (data not shown). Taken
Figure 3.Macrophage/microglia–mediated cytotoxicity against murine melanoma cells. LPS + IFN-γ–activated macrophages and microglia
(shaded bars) induced significantly higher levels of cytotoxicity in B16-BL6 and K-1735 C4 cells compared with unactivated microglia/
macrophages (unshaded bars). Data are representative of three independent experiments. Percent cytotoxicity ± SD.
Figure 2. Immunofluorescent analysis of metastases in the brain of normal C57BL/6 mouse parabiosed to transgenic GFP+ mouse. CD68
and Iba-1 were coded red, F4/80 was coded blue, and nuclei were coded gray. Cells from transgenic green fluorescent mice (GFP+) were
captured green. Mouse lung tumor metastases in the mouse brain were infiltrated by cells from both the GFP+ mouse and the wild-type
C57BL/6 mouse. Infiltrating cells were macrophages from either the wild-type C57BL/6 mouse (blue and pink) or the GFP+ mouse (sky blue
andwhite) andmicroglial cells fromeither thewild-type C57BL/6mouse (red) or theGFP+mouse (yellow). Infiltrating cells expressing neither
CD68/Iba-1 nor F4/80 were also found. Color codes were illustrated in the figure, and cells were indicated by arrows of relevant colors.
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together, these observations suggest that the cytotoxic effects produced
by microglia are discriminate. That is, activated microglia specifically
and selectively induce tumoricidal effects.
Activated microglia can induce cytotoxicity in a variety cell types in
various CNS pathologies and in specific cell types during CNS devel-
opment [25,44–46]. Microglia-derived NO potentially harms cells,
and it has been implicated in contributing to oxidative damage and
subsequent cell death in a variety of neurologic pathologies [23]. Recent
work links microglial-induced neuronal toxicity to iNOS activity and
iNOS expression is associated with microglia surrounding brain metas-
tasis in humans [24,25,46]. We examined the activity of iNOS and
subsequent production of nitrate, a stable breakdown product of NO
in activated and nonactivated microglia and in macrophages. LPS +
IFN-γ–activated microglia and macrophages produced significantly
more nitrate at all time points measured from 24 to 72 hours (Figure 4).
Moreover, previous work from our laboratory has related comparable
levels of nitrate to tumor cell cytotoxicity [41]. To test the contribution
of NO to the observed microglial-induced cytotoxicity, we pretreated
C8-B4 cells with an iNOS inhibitor, NMA, before their activation.
Microglia pretreated with NMA failed to induce cytotoxicity in B16-
BL6 melanoma cells (Figure 4). These results demonstrate that iNOS
activity and subsequent NO production significantly contribute to
microglial-induced tumor cell death.
Given the robust cytotoxicity against B16-BL6mediated by activated
microglia, we confirmed their physical interaction by electron micros-
copy. We observed that multiple microglial cells interact with a single
melanoma cell, forming several tether-like contacts with the tumor cell,
similar to what is seen between macrophages and tumor cells (data not
shown). To determine whether these physical contacts are necessary to
produce cytotoxicity, we used a transwell assay system to prevent physi-
cal association between activated microglia and melanoma cells but
maintain a common medium between the two cell types. Activated mi-
croglia produced 85% to 90% cytotoxicity in tumor cells regardless of
contact. These data suggest that the factors exchanged between the cells
via the medium mediate the cytotoxic effects of microglia. Like macro-
phages, activated microglia, therefore, induce both direct and indirect
cytotoxicity in B16 tumor cells [40].
To prove that the cytotoxic effects mediated by activated microglia
were not specific to only melanoma cells, we tested their tumoricidal
effects inmultiple murine and human cancer cell lines. In all cells tested,
we observedmicroglial induced cytotoxicity, to varying extents (Table 2).
No differences were observed between tumor cells from mouse or
human origin. The B16-BL6 cells responded most dramatically with
83.4% cytotoxicity, whereas the Lewis lung carcinoma cells, 3LL LM,
Table 1. Murine Microglia Fail to Induce Cytotoxicity in Normal Cells.
Origin Target Cell Mean Cytotoxicity (%)
Murine Brain endothelial cells −0.1 ± 11.2
3T3 fibroblasts −2 ± 9.4
Astrocytes −6.3 ± 7.7
Human Fibroblasts −1.1 ± 10.7
Astrocytes −3.4 ± 9.2
3H-thymidine–labeled target cells in triplicate were cultured alone or with LPS/IFN-γ–activated
C8-B4microglia at a ratio of 1:5. Cells were lysed 72 hours later in 0.1M KOH, and radioactivity was
measured. Percentage cytotoxicity was calculated as the ratio to 3H-thymidine–labeled tumor cells
cultured alone. Data are given as mean cytotoxicity ± SD.
Figure 4. Tumoricidal activity of activatedmicroglia andmacrophages ismediatedbyNO.Unactivated (unshadedbars) and activated (shaded
bars) C8-B4microglia were incubated for 24 to 72 hours before being subjected to the Griess assay. Cell culture supernatants were tested in
triplicate for production of nitrate. Data are the representative of 3 independent experiments. Error bars represent SD. *P < .001. 3H-TdR–
labeled B16 melanoma cells were incubated with either LPS + IFN-γ–activated C8-B4 microglia or LPS + IFN-γ–activated murine macro-
phages in the presence or absence of 3 mM NMA for 72 hours. NMA reduced the microglial or macrophage mediated cytotoxicity by
∼90%. Data are representative of three independent experiments. Error bars represent SD. *P < .0005.
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were most resistant to the effects of microglia (32.8% cytotoxicity).
Various human breast cancer cells (GI101A, MDA-231P), human
lung cancer cells (PC14P), human glioblastoma cells (U87), and mouse
(K-1735 C4) and human (A375P) melanoma cells were all susceptible
to the tumoricidal effects of activated microglia.
Discussion
Microglia are the major immune effector cells of the CNS and are com-
monly called the macrophages of the brain [1,2]. Expression of both
macrophages and microglia is often associated with experimental and
human brain metastases [25–30], we therefore sought to determine
whether microglia possess tumoricidal activity in vitro. We discovered
that indeed LPS + IFN-γ–activated microglia behave much like macro-
phages and exert tumoricidal effects against various types of cancer cells,
confirming previous reports that activatedmicroglia are cytotoxic tome-
tastatic cancer cells [25]. In addition, we observed that activated micro-
glia had no cytotoxic effects on normal cells. The tumoricidal activity
of microglia is primarily mediated by the release of NO. We base this
conclusion on the data showing that tumor cell cytotoxicity is potently
inhibited by the addition of the iNOS inhibitor, NMA. We have previ-
ously shown that this mechanism is also responsible for macrophage-
induced tumor cell death [41,47].Whereas functional contacts between
microglia and tumor cells were observed using electron microscopy, we
discovered that contact between tumor cells and microglia is not a pre-
requisite to induce cytotoxicity, further implicating the freely diffusible
molecule NO in this process. Because microglia possess potent tumori-
cidal activity in vitro, we examined their expression in vivo and observed
that experimental mouse lung cancer metastases in the brain paren-
chyma were infiltrated by cells of various subpopulations, including
the specialized macrophages, microglia.
Current work in brain metastasis has highlighted the role of cells of
the brain microenvironment in this process. The organ microenviron-
ment can alter the ability of tumor cells to “seed” the organ and modify
the response of metastatic tumor cells to therapy [48,49]. Recently, our
laboratory has characterized the expression and localization of reactive
astrocytes surrounding brain metastasis of human cancer cells [26]. Fur-
thermore, we have recently described the chemoprotective role of astro-
cytes in brain metastasis [50]. In this study, we examined the effects
of microglia on tumor cells. Microglia are considered to be the most
important immune effector cells in the CNS, but the function of micro-
glia in brain metastasis is not well described. Immunohistochemical
analysis of brain metastases in patients reveals expression of activated
microglia surrounding areas of tumor burden, and the presence of
bothmacrophages andmicroglia is widely reported in both experimental
and clinical human brain metastases [25–28,30]. We determined the
in vitro function of microglia by examining the ability of LPS + IFN-
γ–activated microglia to induce cytotoxicity in cancer cells. Previous
work describes that LPS + IFN-γ–activated microglia exhibit tumorici-
dal activity against colon cancer cells [51]. Further studies revealed that
supernatants from LPS-activated microglia induced apoptosis in meta-
static lung cancer cells [25]. Using the C8-B4 microglial cell line, we
examined the effects of LPS + IFN-γ–activatedmicroglia on tumor cells
and observed microglial-induced cytotoxicity in B16-BL6 and K-1735
C4 melanoma cells that was comparable to that induced by macro-
phages. Interestingly, activated microglia do not select for “resistant” tu-
mor cells. Tumor cells that survive after being cultured once with
activated microglia do not exhibit any acquired resistance to a second
round of microglial-induced cytotoxicity (data not shown). In addition,
when activatedmicroglia were cultured with cells of normal origin, such
as 3T3 fibroblasts, murine astrocytes, and immortalized murine brain
endothelial cells, there were no discernable toxic effects (Table 1).More-
over, microglia selectively killed B16-BL6 melanoma cells when the tu-
mor cells were admixed with 3T3 fibroblasts (data not shown). The
precise mechanism of the observed specificity of microglia-mediated cy-
totoxicity is unclear. However, we have previously demonstrated that
tumor cells express higher levels of phosphatidylserine (PS) in the outer
membrane leaflet, compared with cells of normal origin [15,52]. Inter-
estingly, IFN-γ and LPS-activated monocytes are capable of recognizing
elevated levels of PS and targeting these cells for lysis [53]. Because ac-
tivated microglia largely behave in the same way as activated macro-
phages, it is likely that PS also serves as a recognition signal for
triggering microglial-induced tumor cell death. This mechanism is cur-
rently being explored.
On activation, microglia are capable of producing a variety of neuro-
active molecules, such as cytokines and chemokines, including IL-1,
IL-6, TNF-α, andTGF-β as well as radicals, such asNOand superoxide
[52]. A major diffusible mediator that can produce death in adjacent
tumor cells is NO, which is regulated by the activity of iNOS [47,54].
Previous work from our laboratory revealed that tumoricidal activity of
macrophages is mediated through NO release [41,55]. NO is thought
to induce death of neurons near microglia [24]. Furthermore, data sug-
gest that microglia exert cytotoxic effects on colon cancer cells through
NO [38]. Indeed, we observed significantly higher levels of nitrate, a
stable breakdown product of NO, in both activated microglia and
macrophages. We also demonstrate that, like macrophages, the mecha-
nism of microglia-induced tumoricidal activity is mainly due to NO. In-
hibition of iNOS activity in either microglia or macrophages nearly
completely abrogated the tumoricidal effects on B16-BL6 cells.
On the basis of the specific cytotoxic behavior of microglia on tumor
cells in vitro, we were interested in observing these cells in a brainmetas-
tasis model. Using a parabiosis model, we found the presence of micro-
glia (specialized macrophages) in the lesions formed by metastatic lung
cancer. Because this parabiosis model provides common physiologic
circulation between wild-type and GFP mice, the origin of cells can be
clearly identified by the presence of GFP+ cells in the brain of wild-type
mouse. The finding of F4/80+ cells and GFP+, F4/80+, CD68+ cells
suggested that some circulating monocytes infiltrated these lesions. Im-
portantly, we also found infiltrating cells that expressed neither CD68
nor F4/80. Hence, other inflammatory cells also infiltrate the tumors
in the brain. These results confirm that metastases in the brain are in-
filtrated by both residual cells and circulating cells. Importantly, these
data also corroborate previous reports that unlike other glial cells, such
as astrocytes and oligodendrocytes that originate in the neuroectoderm,
microglia are derived from circulating blood monocytes and are capable
of repopulating the brain during pathologic conditions [25,26,30,
44,56–59].
Table 2. Murine Microglia–Mediated Cytotoxicity against Tumor Cells.
Origin Target Cell Mean Cytotoxicity (%)
Murine B16-BL6 melanoma 83.4 ± 8.7
K-1735 C4 melanoma 73.3 ± 11.2
3LL lung cancer 32.8 ± 3.7
Human GI101A breast cancer 78.6 ± 4.0
MDA231P breast cancer 33.7 ± 2.3
A375P melanoma 68.6 ± 2.7
U87 glioblastoma 55.0 ± 9.9
PC14P lung cancer 46.4 ± 11.9
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In summary, our results demonstrate that microglia behave nearly
identically to macrophages and exhibit selective and specific tumoricidal
activity. Our experiments also reveal that microglia, which are derived
from circulating mononuclear cells, are recruited to metastases in the
brain. To our knowledge, this is the first demonstration of the selective
and specific ability of microglia to target tumor cells for cell death. Gain-
ing insight into the interactions between cells of the brain microenvi-
ronment, such as microglia, and metastatic tumor cells is extremely
important for a better understanding of the biology of brain metastasis.
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